Product |
CAS |
Molecular formula |
More |
Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)- |
67469-57-2 |
C28H32N2O |
More |
N-[3-[[2-(4-Aminofurazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]o |
850664-21-0 |
C29H30N8O5 |
More |
2-Thiophenecarboxamide, 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[2-( |
660868-91-7 |
C22H18F3N3O4S |
More |
5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amin |
635702-64-6 |
C21H23N7O2S.ClH |
More |
3-Phenylsulfonyl-8-(piperazin-1-yl)quinoline |
607742-69-8 |
C19H19N3O2S |
More |
2H-Pyrrolo[3,2-b]pyridin-2-one, 1,3-dihydro-3-[(1-methyl-1H-indol-3-yl |
504433-23-2 |
C17H13N3O |
More |
2-[3-[3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino] |
405911-17-3 |
C33H31ClF3NO3.HCl |
More |
Benzeneacetic acid, 3-[3-[[[2-chloro-3-(trifluoromethyl)phenyl]methyl] |
405911-09-3 |
C33H31ClF3NO3 |
More |
Propanoic acid, 2-[[4-[2-[[(cyclohexylamino)carbonyl](4-cyclohexylbuty |
265129-71-3 |
C29H46N2O3S |
More |
Methanesulfonic acid, 1,1,1-trifluoro-, 8-chloro-11-(4-methyl-1-pipera |
234113-94-1 |
C19H18ClF3N4O3S |
More |
1-(4-Aminophenyl)-3-methylcarbamoyl-4-methyl-7,8-methylenedioxy-3,4-di |
143692-18-6 |
C19H20N4O3 |
More |
Morpholine, 4-[[2-[2-(acetyloxy)ethyl]-2,3-dihydro-4-methyl-1,3-dioxo- |
745046-84-8 |
C20H21N3O7S |
More |
Pyridine, 4-(1H-imidazol-4-ylmethyl)-, dihydrobromide |
699020-93-4 |
C9H9N3.2HBr |
More |
Piperidine, 4-(1H-imidazol-4-ylmethyl)-, dihydrobromide |
164391-47-3 |
C9H15N3.2HBr |
More |
Pyridine, 4-(1H-imidazol-4-ylmethyl)- |
87976-03-2 |
C9H9N3 |
More |
8-Hydroxy-2-dipropylaminotetralin hydrobromide |
76135-31-4 |
C16H25NO.HBr |
More |
7-Hydroxy-2-dipropylaminotetralin hydrobromide |
76135-30-3 |
C16H25NO.HBr |
More |
Piperazine, 1-[(5-chloro-1H-indol-2-yl)carbonyl]-4-methyl- |
459168-41-3 |
C14H16ClN3O |
More |
1,2,4-Triazolo[4,3-b]pyridazine, 3-(2,5-difluorophenyl)-7-(1,1-dimethy |
286456-42-6 |
C19H19F2N7O |
More |
1H-2,1,3-Benzothiadiazine, 1-[2-[4-(6-fluoro-1H-indol-3-yl)-3,6-dihydr |
271780-64-4 |
C26H31FN4O4S2 |
More |